{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:15:56Z","timestamp":1790961356376,"version":"4.1.0"},"reference-count":153,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["PID2020-120336RB-I00"],"award-info":[{"award-number":["PID2020-120336RB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["PI18\/00209"],"award-info":[{"award-number":["PI18\/00209"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["PI19\/01360"],"award-info":[{"award-number":["PI19\/01360"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["FI20\/00033"],"award-info":[{"award-number":["FI20\/00033"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["PI21\/00220"],"award-info":[{"award-number":["PI21\/00220"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["PROMETEO\/2019\/032"],"award-info":[{"award-number":["PROMETEO\/2019\/032"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["Gent T CDEI-04\/20-A"],"award-info":[{"award-number":["Gent T CDEI-04\/20-A"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["AICO\/2019\/250"],"award-info":[{"award-number":["AICO\/2019\/250"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["AICO\/2021\/035"],"award-info":[{"award-number":["AICO\/2021\/035"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["CP21\/00025"],"award-info":[{"award-number":["CP21\/00025"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PID2020-120336RB-I00"],"award-info":[{"award-number":["PID2020-120336RB-I00"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI18\/00209"],"award-info":[{"award-number":["PI18\/00209"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI19\/01360"],"award-info":[{"award-number":["PI19\/01360"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["FI20\/00033"],"award-info":[{"award-number":["FI20\/00033"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI21\/00220"],"award-info":[{"award-number":["PI21\/00220"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PROMETEO\/2019\/032"],"award-info":[{"award-number":["PROMETEO\/2019\/032"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["Gent T CDEI-04\/20-A"],"award-info":[{"award-number":["Gent T CDEI-04\/20-A"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["AICO\/2019\/250"],"award-info":[{"award-number":["AICO\/2019\/250"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["AICO\/2021\/035"],"award-info":[{"award-number":["AICO\/2021\/035"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["CP21\/00025"],"award-info":[{"award-number":["CP21\/00025"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["PID2020-120336RB-I00"],"award-info":[{"award-number":["PID2020-120336RB-I00"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["PI18\/00209"],"award-info":[{"award-number":["PI18\/00209"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["PI19\/01360"],"award-info":[{"award-number":["PI19\/01360"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["FI20\/00033"],"award-info":[{"award-number":["FI20\/00033"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["PI21\/00220"],"award-info":[{"award-number":["PI21\/00220"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["PROMETEO\/2019\/032"],"award-info":[{"award-number":["PROMETEO\/2019\/032"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["Gent T CDEI-04\/20-A"],"award-info":[{"award-number":["Gent T CDEI-04\/20-A"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["AICO\/2019\/250"],"award-info":[{"award-number":["AICO\/2019\/250"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["AICO\/2021\/035"],"award-info":[{"award-number":["AICO\/2021\/035"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["CP21\/00025"],"award-info":[{"award-number":["CP21\/00025"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Regional Development Fund (FEDER)","award":["PID2020-120336RB-I00"],"award-info":[{"award-number":["PID2020-120336RB-I00"]}]},{"name":"European Regional Development Fund (FEDER)","award":["PI18\/00209"],"award-info":[{"award-number":["PI18\/00209"]}]},{"name":"European Regional Development Fund (FEDER)","award":["PI19\/01360"],"award-info":[{"award-number":["PI19\/01360"]}]},{"name":"European Regional Development Fund (FEDER)","award":["FI20\/00033"],"award-info":[{"award-number":["FI20\/00033"]}]},{"name":"European Regional Development Fund (FEDER)","award":["PI21\/00220"],"award-info":[{"award-number":["PI21\/00220"]}]},{"name":"European Regional Development Fund (FEDER)","award":["PROMETEO\/2019\/032"],"award-info":[{"award-number":["PROMETEO\/2019\/032"]}]},{"name":"European Regional Development Fund (FEDER)","award":["Gent T CDEI-04\/20-A"],"award-info":[{"award-number":["Gent T CDEI-04\/20-A"]}]},{"name":"European Regional Development Fund (FEDER)","award":["AICO\/2019\/250"],"award-info":[{"award-number":["AICO\/2019\/250"]}]},{"name":"European Regional Development Fund (FEDER)","award":["AICO\/2021\/035"],"award-info":[{"award-number":["AICO\/2021\/035"]}]},{"name":"European Regional Development Fund (FEDER)","award":["CP21\/00025"],"award-info":[{"award-number":["CP21\/00025"]}]},{"DOI":"10.13039\/501100004587","name":"European Social Fund Plus (ESF+)","doi-asserted-by":"publisher","award":["PID2020-120336RB-I00"],"award-info":[{"award-number":["PID2020-120336RB-I00"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"European Social Fund Plus (ESF+)","doi-asserted-by":"publisher","award":["PI18\/00209"],"award-info":[{"award-number":["PI18\/00209"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"European Social Fund Plus (ESF+)","doi-asserted-by":"publisher","award":["PI19\/01360"],"award-info":[{"award-number":["PI19\/01360"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"European Social Fund Plus (ESF+)","doi-asserted-by":"publisher","award":["FI20\/00033"],"award-info":[{"award-number":["FI20\/00033"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"European Social Fund Plus (ESF+)","doi-asserted-by":"publisher","award":["PI21\/00220"],"award-info":[{"award-number":["PI21\/00220"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"European Social Fund Plus (ESF+)","doi-asserted-by":"publisher","award":["PROMETEO\/2019\/032"],"award-info":[{"award-number":["PROMETEO\/2019\/032"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"European Social Fund Plus (ESF+)","doi-asserted-by":"publisher","award":["Gent T CDEI-04\/20-A"],"award-info":[{"award-number":["Gent T CDEI-04\/20-A"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"European Social Fund Plus (ESF+)","doi-asserted-by":"publisher","award":["AICO\/2019\/250"],"award-info":[{"award-number":["AICO\/2019\/250"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"European Social Fund Plus (ESF+)","doi-asserted-by":"publisher","award":["AICO\/2021\/035"],"award-info":[{"award-number":["AICO\/2021\/035"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"European Social Fund Plus (ESF+)","doi-asserted-by":"publisher","award":["CP21\/00025"],"award-info":[{"award-number":["CP21\/00025"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CiberEHD","award":["PID2020-120336RB-I00"],"award-info":[{"award-number":["PID2020-120336RB-I00"]}]},{"name":"CiberEHD","award":["PI18\/00209"],"award-info":[{"award-number":["PI18\/00209"]}]},{"name":"CiberEHD","award":["PI19\/01360"],"award-info":[{"award-number":["PI19\/01360"]}]},{"name":"CiberEHD","award":["FI20\/00033"],"award-info":[{"award-number":["FI20\/00033"]}]},{"name":"CiberEHD","award":["PI21\/00220"],"award-info":[{"award-number":["PI21\/00220"]}]},{"name":"CiberEHD","award":["PROMETEO\/2019\/032"],"award-info":[{"award-number":["PROMETEO\/2019\/032"]}]},{"name":"CiberEHD","award":["Gent T CDEI-04\/20-A"],"award-info":[{"award-number":["Gent T CDEI-04\/20-A"]}]},{"name":"CiberEHD","award":["AICO\/2019\/250"],"award-info":[{"award-number":["AICO\/2019\/250"]}]},{"name":"CiberEHD","award":["AICO\/2021\/035"],"award-info":[{"award-number":["AICO\/2021\/035"]}]},{"name":"CiberEHD","award":["CP21\/00025"],"award-info":[{"award-number":["CP21\/00025"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is currently the most prevalent chronic liver disease in Western countries, affecting approximately 25% of the adult population. This condition encompasses a spectrum of liver diseases characterized by abnormal accumulation of fat in liver tissue (non-alcoholic fatty liver, NAFL) that can progress to non-alcoholic steatohepatitis (NASH), characterized by the presence of liver inflammation and damage. The latter form often coexists with liver fibrosis which, in turn, may progress to a state of cirrhosis and, potentially, hepatocarcinoma, both irreversible processes that often lead to the patient\u2019s death and\/or the need for liver transplantation. Along with the high associated economic burden, the high mortality rate among NAFLD patients raises interest, not only in the search for novel therapeutic approaches, but also in early diagnosis and prevention to reduce the incidence of NAFLD-related complications. In this line, an exhaustive characterization of the immune status of patients with NAFLD is mandatory. Herein, we attempted to gather and compare the current and relevant scientific evidence on this matter, mainly on human reports. We addressed the current knowledge related to circulating cellular and soluble mediators, particularly platelets, different leukocyte subsets and relevant inflammatory soluble mediators.<\/jats:p>","DOI":"10.3390\/ijms24032313","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T03:53:18Z","timestamp":1674618798000},"page":"2313","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0465-1727","authenticated-orcid":false,"given":"Patrice","family":"Marques","sequence":"first","affiliation":[{"name":"Institute of Health Research INCLIVA, University Clinic Hospital of Valencia, 46010 Valencia, Spain"},{"name":"Department of Pharmacology, Faculty of Medicine and Odontology, University of Valencia, 46010 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2404-6607","authenticated-orcid":false,"given":"Vera","family":"Francisco","sequence":"additional","affiliation":[{"name":"Institute of Health Research INCLIVA, University Clinic Hospital of Valencia, 46010 Valencia, Spain"},{"name":"Endocrinology and Nutrition Service, University Clinic Hospital of Valencia, 46010 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0683-8651","authenticated-orcid":false,"given":"Laura","family":"Mart\u00ednez-Arenas","sequence":"additional","affiliation":[{"name":"Liver Transplantation and Hepatology Laboratory, Hepatology, HBP Surgery and Transplant Unit, Health Research Institute Hospital La Fe, La Fe University Hospital, 46026 Valencia, Spain"},{"name":"CIBEREHD, Spanish Biomedical Research Centre in Hepatic and Digestive Diseases, Carlos III Health Institute (ISCIII), 28029 Madrid, Spain"},{"name":"Department of Biotechnology, School of Agricultural Engineering and Environment, Universitat Polit\u00e8cnica de Val\u00e8ncia, 46022 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5424-3479","authenticated-orcid":false,"given":"\u00c2ngela","family":"Carvalho-Gomes","sequence":"additional","affiliation":[{"name":"Liver Transplantation and Hepatology Laboratory, Hepatology, HBP Surgery and Transplant Unit, Health Research Institute Hospital La Fe, La Fe University Hospital, 46026 Valencia, Spain"},{"name":"CIBEREHD, Spanish Biomedical Research Centre in Hepatic and Digestive Diseases, Carlos III Health Institute (ISCIII), 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Domingo","sequence":"additional","affiliation":[{"name":"Institute of Health Research INCLIVA, University Clinic Hospital of Valencia, 46010 Valencia, Spain"},{"name":"Department of Pharmacology, Faculty of Medicine and Odontology, University of Valencia, 46010 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8010-5168","authenticated-orcid":false,"given":"Laura","family":"Piqueras","sequence":"additional","affiliation":[{"name":"Institute of Health Research INCLIVA, University Clinic Hospital of Valencia, 46010 Valencia, Spain"},{"name":"Department of Pharmacology, Faculty of Medicine and Odontology, University of Valencia, 46010 Valencia, Spain"},{"name":"CIBERDEM, Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders, Carlos III Health Institute (ISCIII), 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9246-4264","authenticated-orcid":false,"given":"Marina","family":"Berenguer","sequence":"additional","affiliation":[{"name":"Liver Transplantation and Hepatology Laboratory, Hepatology, HBP Surgery and Transplant Unit, Health Research Institute Hospital La Fe, La Fe University Hospital, 46026 Valencia, Spain"},{"name":"CIBEREHD, Spanish Biomedical Research Centre in Hepatic and Digestive Diseases, Carlos III Health Institute (ISCIII), 28029 Madrid, Spain"},{"name":"Department of Medicine, Faculty of Medicine and Odontology, University of Valencia, 46010 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8885-294X","authenticated-orcid":false,"given":"Maria-Jesus","family":"Sanz","sequence":"additional","affiliation":[{"name":"Institute of Health Research INCLIVA, University Clinic Hospital of Valencia, 46010 Valencia, Spain"},{"name":"Department of Pharmacology, Faculty of Medicine and Odontology, University of Valencia, 46010 Valencia, Spain"},{"name":"CIBERDEM, Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders, Carlos III Health Institute (ISCIII), 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.metabol.2018.09.005","article-title":"The epidemiology of obesity","volume":"92","author":"Chooi","year":"2019","journal-title":"Metab. Clin. Exp."},{"key":"ref_2","unstructured":"WHO (2022, July 15). European Regional Obesity Report 2022, Available online: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/353747\/9789289057738-eng.pdf."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Tarantino, G., Citro, V., and Capone, D. (2019). Nonalcoholic Fatty Liver Disease: A Challenge from Mechanisms to Therapy. J. Clin. Med., 9.","DOI":"10.3390\/jcm9010015"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease\u2014A global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_6","first-page":"1254","article-title":"What\u2019s in a name? Renaming \u2018NAFLD\u2019 to \u2018MAFLD\u2019","volume":"40","author":"Fouad","year":"2020","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fmed.2019.00202","article-title":"Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis-Literature Review","volume":"6","author":"Ismaiel","year":"2019","journal-title":"Front. Med."},{"key":"ref_9","first-page":"2809","article-title":"2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis","volume":"20","author":"Le","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/MEG.0b013e32832fcdf0","article-title":"Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain","volume":"22","author":"Pera","year":"2010","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","article-title":"NAFLD and cardiovascular diseases: A clinical review","volume":"110","author":"Kasper","year":"2021","journal-title":"Clin. Res. Cardiol. Off. J. Ger. Card. Soc."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"100192","DOI":"10.1016\/j.jhepr.2020.100192","article-title":"NAFLD and liver transplantation: Disease burden, current management and future challenges","volume":"2","author":"Burra","year":"2020","journal-title":"JHEP Rep. Innov. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.aohep.2019.06.014","article-title":"Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis","volume":"18","author":"Aguilera","year":"2019","journal-title":"Ann. Hepatol."},{"key":"ref_14","first-page":"10263","article-title":"Mortality and Causes of Death After Liver Transplantation: Analysis of Sex Differences in a Large Nationwide Cohort","volume":"35","author":"Serrano","year":"2022","journal-title":"Transpl. Int. Off. J. Eur. Soc. Organ Transplant."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10198-020-01256-y","article-title":"Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018","volume":"22","author":"Morgan","year":"2021","journal-title":"Eur. J. Health Econ."},{"key":"ref_16","first-page":"100142","article-title":"Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study","volume":"2","author":"Finnegan","year":"2020","journal-title":"JHEP Rep. Innov. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3748\/wjg.v18.i8.727","article-title":"Role of cytokines and chemokines in non-alcoholic fatty liver disease","volume":"18","author":"Braunersreuther","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Tana, C., Ballestri, S., Ricci, F., Di Vincenzo, A., Ticinesi, A., Gallina, S., Giamberardino, M.A., Cipollone, F., Sutton, R., and Vettor, R. (2019). Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications. Int. J. Environ. Res. Public Health, 16.","DOI":"10.3390\/ijerph16173104"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Diedrich, T., Kummer, S., Galante, A., Drolz, A., Schlicker, V., Lohse, A.W., Kluwe, J., Eberhard, J.M., and Schulze zur Wiesch, J. (2020). Characterization of the immune cell landscape of patients with NAFLD. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0230307"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: A tale of two \u201chits\u201d?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"11053","DOI":"10.3748\/wjg.v21.i39.11053","article-title":"Endocrine causes of nonalcoholic fatty liver disease","volume":"21","author":"Marino","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41419-020-2411-6","article-title":"TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice","volume":"11","author":"Wandrer","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00281-022-00910-2","article-title":"TNF in the liver: Targeting a central player in inflammation","volume":"44","author":"Tiegs","year":"2022","journal-title":"Semin. Immunopathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/hep.30506","article-title":"The Role of Innate Immune Cells in Nonalcoholic Steatohepatitis","volume":"70","author":"Cai","year":"2019","journal-title":"Hepatology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/hep.31518","article-title":"Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade","volume":"73","author":"Tilg","year":"2021","journal-title":"Hepatology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1053\/j.gastro.2016.01.025","article-title":"Inflammation in Alcoholic and Nonalcoholic Fatty Liver Disease: Friend or Foe?","volume":"150","author":"Gao","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MD.0b013e3182779d49","article-title":"Nonalcoholic fatty liver disease in lean individuals in the United States","volume":"91","author":"Younossi","year":"2012","journal-title":"Medicine"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41419-021-03872-9","article-title":"Adipocyte death triggers a pro-inflammatory response and induces metabolic activation of resident macrophages","volume":"12","author":"Lindhorst","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fimmu.2019.00082","article-title":"The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity","volume":"10","author":"Weyler","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-981-10-8684-7_9","article-title":"Microbiota, Obesity and NAFLD","volume":"1061","author":"Lau","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","article-title":"The gut-liver axis and the intersection with the microbiome","volume":"15","author":"Tripathi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e9302","DOI":"10.15252\/emmm.201809302","article-title":"The role of the microbiome in NAFLD and NASH","volume":"11","author":"Kolodziejczyk","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Francisco, V., Sanz, M.J., Real, J.T., Marques, P., Capuozzo, M., Ait Eldjoudi, D., and Gualillo, O. (2022). Adipokines in Non-Alcoholic Fatty Liver Disease: Are We on the Road toward New Biomarkers and Therapeutic Targets?. Biology, 11.","DOI":"10.3390\/biology11081237"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jhepr.2019.10.001","article-title":"Platelets in chronic liver disease, from bench to bedside","volume":"1","author":"Ramadori","year":"2019","journal-title":"JHEP Rep. Innov. Hepatol."},{"key":"ref_38","first-page":"778","article-title":"Thrombocytopenia in chronic liver disease","volume":"37","year":"2017","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Mussbacher, M., Brunnthaler, L., Panhuber, A., Starlinger, P., and Assinger, A. (2021). Till Death Do Us Part-The Multifaceted Role of Platelets in Liver Diseases. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22063113"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41591-019-0379-5","article-title":"Platelet GPIb\u03b1 is a mediator and potential interventional target for NASH and subsequent liver cancer","volume":"25","author":"Malehmir","year":"2019","journal-title":"Nat. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1182\/blood-2017-12-820779","article-title":"GPIb\u03b1 is required for platelet-mediated hepatic thrombopoietin generation","volume":"132","author":"Xu","year":"2018","journal-title":"Blood"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00428-022-03330-7","article-title":"Neutrophil extracellular traps enriched with IL-1\u03b2 and IL-17A participate in the hepatic inflammatory process of patients with non-alcoholic steatohepatitis","volume":"481","author":"Arelaki","year":"2022","journal-title":"Virchows Arch. Int. J. Pathol."},{"key":"ref_43","first-page":"6070135","article-title":"Diagnostic Accuracy of Platelet Count and Platelet Indices in Noninvasive Assessment of Fibrosis in Nonalcoholic Fatty Liver Disease Patients","volume":"2017","author":"Dumic","year":"2017","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"9882","DOI":"10.12659\/MSM.920172","article-title":"Evaluation of Plateletcrit and Platelet Distribution Width in Patients with Non-Alcoholic Fatty Liver Disease: A Retrospective Chart Review Study","volume":"25","author":"Oral","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12944-018-0865-7","article-title":"Risk of reduced platelet counts in patients with nonalcoholic fatty liver disease (NAFLD): A prospective cohort study","volume":"17","author":"Liu","year":"2018","journal-title":"Lipids Health Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e24449","DOI":"10.5812\/hepatmon.24449","article-title":"Association between platelet count as a noninvasive marker and ultrasonographic grading in patients with nonalcoholic Fatty liver disease","volume":"15","author":"Garjani","year":"2015","journal-title":"Hepat. Mon."},{"key":"ref_47","first-page":"75","article-title":"Comparison of platelet number and function between nonalcoholic fatty liver disease and normal individuals","volume":"22","author":"Saremi","year":"2017","journal-title":"J. Res. Med. Sci. Off. J. Isfahan Univ. Med. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/MEG.0000000000000486","article-title":"A novel model using mean platelet volume and neutrophil to lymphocyte ratio as a marker of nonalcoholic steatohepatitis in NAFLD patients: Multicentric study","volume":"28","author":"Mousa","year":"2016","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/hep.24721","article-title":"Mean platelet volume as a marker of increased cardiovascular risk in patients with nonalcoholic steatohepatitis","volume":"55","author":"Alkhouri","year":"2012","journal-title":"Hepatology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/apt.15192","article-title":"Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non-alcoholic fatty liver disease; the importance of an elevated mean platelet volume","volume":"49","author":"Abeles","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1538-7836.2009.03584.x","article-title":"Mean platelet volume as a predictor of cardiovascular risk: A systematic review and meta-analysis","volume":"8","author":"Chu","year":"2010","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Marques, P., Collado, A., Martinez-Herv\u00e1s, S., Domingo, E., Benito, E., Piqueras, L., Real, J.T., Ascaso, J.F., and Sanz, M.-J. (2019). Systemic Inflammation in Metabolic Syndrome: Increased Platelet and Leukocyte Activation, and Key Role of CX(3)CL1\/CX(3)CR1 and CCL2\/CCR2 Axes in Arterial Platelet-Proinflammatory Monocyte Adhesion. J. Clin. Med., 8.","DOI":"10.3390\/jcm8050708"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Collado, A., Marques, P., Domingo, E., Perello, E., Gonz\u00e1lez-Navarro, H., Martinez-Herv\u00e1s, S., Real, J.T., Piqueras, L., Ascaso, J.F., and Sanz, M.-J. (2018). Novel Immune Features of the Systemic Inflammation Associated with Primary Hypercholesterolemia: Changes in Cytokine\/Chemokine Profile, Increased Platelet and Leukocyte Activation. J. Clin. Med., 8.","DOI":"10.3390\/jcm8010018"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"112460","DOI":"10.1016\/j.biopha.2021.112460","article-title":"Beneficial effects of PCSK9 inhibition with alirocumab in familial hypercholesterolemia involve modulation of new immune players","volume":"145","author":"Marques","year":"2022","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"8867985","DOI":"10.1155\/2021\/8867985","article-title":"Plateletcrit and Mean Platelet Volume in the Evaluation of Alcoholic Liver Cirrhosis and Nonalcoholic Fatty Liver Disease Patients","volume":"2021","author":"Michalak","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s12072-020-10081-7","article-title":"The role of neutrophils in innate immunity-driven nonalcoholic steatohepatitis: Lessons learned and future promise","volume":"14","author":"Wu","year":"2020","journal-title":"Hepatol. Int."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000518407","article-title":"The Role of Innate Immune Cells in Nonalcoholic Fatty Liver Disease","volume":"14","author":"Nati","year":"2022","journal-title":"J. Innate Immun."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s12020-017-1323-4","article-title":"Neutrophil depletion improves diet-induced non-alcoholic fatty liver disease in mice","volume":"57","author":"Ou","year":"2017","journal-title":"Endocrine"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.bbrc.2019.08.111","article-title":"Knockout of neutrophil elastase protects against western diet induced nonalcoholic steatohepatitis in mice by regulating hepatic ceramides metabolism","volume":"518","author":"Chen","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Rensen, S.S., Bieghs, V., Xanthoulea, S., Arfianti, E., Bakker, J.A., Shiri-Sverdlov, R., Hofker, M.H., Greve, J.W., and Buurman, W.A. (2012). Neutrophil-derived myeloperoxidase aggravates non-alcoholic steatohepatitis in low-density lipoprotein receptor-deficient mice. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0052411"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/hep4.1566","article-title":"Therapeutic Targeting of Myeloperoxidase Attenuates NASH in Mice","volume":"4","author":"Koop","year":"2020","journal-title":"Hepatol. Commun."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1089\/ars.2014.6108","article-title":"Myeloperoxidase-Hepatocyte-Stellate Cell Cross Talk Promotes Hepatocyte Injury and Fibrosis in Experimental Nonalcoholic Steatohepatitis","volume":"23","author":"Pulli","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4570219","DOI":"10.1155\/2020\/4570219","article-title":"Circulating Neutrophils of Nonalcoholic Steatohepatitis Patients Show an Activated Phenotype and Suppress T Lymphocytes Activity","volume":"2020","author":"Antonucci","year":"2020","journal-title":"J. Immunol. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2353\/ajpath.2009.080999","article-title":"Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis","volume":"175","author":"Rensen","year":"2009","journal-title":"Am. J. Pathol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/hep.29914","article-title":"Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis","volume":"68","author":"Sud","year":"2018","journal-title":"Hepatology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3389\/fimmu.2016.00490","article-title":"Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets","volume":"7","author":"Paquissi","year":"2016","journal-title":"Front. Immunol."},{"key":"ref_67","first-page":"278","article-title":"Neutrophil-Lymphocyte Ratio (NLR) Could Be Better Predictor than C-reactive Protein (CRP) for Liver Fibrosis in Non-alcoholic Steatohepatitis(NASH)","volume":"45","author":"Yilmaz","year":"2015","journal-title":"Ann. Clin. Lab. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1097\/MEG.0000000000000405","article-title":"Neutrophil-to-lymphocyte ratio is not a predictor of liver histology in patients with nonalcoholic fatty liver disease","volume":"27","author":"Kara","year":"2015","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.2174\/1389450116666150531153627","article-title":"IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression","volume":"16","author":"Giles","year":"2015","journal-title":"Curr. Drug Targets"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Gadd, V.L., Patel, P.J., Jose, S., Horsfall, L., Powell, E.E., and Irvine, K.M. (2016). Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0157771"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1160\/TH16-02-0091","article-title":"Role and analysis of monocyte subsets in cardiovascular disease. Joint consensus document of the European Society of Cardiology (ESC) Working Groups \u201cAtherosclerosis & Vascular Biology\u201d and \u201cThrombosis\u201d","volume":"116","author":"Weber","year":"2016","journal-title":"Thromb. Haemost."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1620\/tjem.223.227","article-title":"Elevated peripheral blood monocyte fraction in nonalcoholic fatty liver disease","volume":"223","author":"Kim","year":"2011","journal-title":"Tohoku J. Exp. Med."},{"key":"ref_73","first-page":"54","article-title":"A Nonclassical Monocyte Phenotype in Peripheral Blood is Associated with Nonalcoholic Fatty Liver Disease: A Report from an EMIL Subcohort","volume":"48","author":"Wang","year":"2016","journal-title":"Horm. Metab. Res. = Horm.-Und Stoffwechs. = Horm. Et Metab."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s00508-018-1348-6","article-title":"Increased intermediate monocyte fraction in peripheral blood is associated with nonalcoholic fatty liver disease","volume":"130","author":"Zhang","year":"2018","journal-title":"Wien. Klin. Wochenschr."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3389\/fimmu.2019.00563","article-title":"Targeting Myeloid-Derived Cells: New Frontiers in the Treatment of Non-alcoholic and Alcoholic Liver Disease","volume":"10","author":"Vonghia","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Arias-Loste, M.T., Iruzubieta, P., Puente, \u00c1., Ramos, D., Santa Cruz, C., Est\u00e9banez, \u00c1., Llerena, S., Alonso-Mart\u00edn, C., San Segundo, D., and \u00c1lvarez, L. (2016). Increased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17111878"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.freeradbiomed.2018.06.015","article-title":"B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD)","volume":"124","author":"Sutti","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3350\/cmh.2019.0074","article-title":"Limited expression of TLR9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease","volume":"26","author":"Alegre","year":"2020","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.3748\/wjg.v20.i23.7381","article-title":"Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease","volume":"20","author":"Miura","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"G270","DOI":"10.1152\/ajpgi.00304.2014","article-title":"Hepatic TLR4 signaling in obese NAFLD","volume":"309","author":"Sharifnia","year":"2015","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1665-2681(19)30769-0","article-title":"Development of steatohepatitis in Ob\/Ob mice is dependent on Toll-like receptor 4","volume":"14","author":"Sutter","year":"2015","journal-title":"Ann. Hepatol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4049\/jimmunol.1501175","article-title":"Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17\/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver","volume":"196","author":"Rau","year":"2016","journal-title":"J. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1007\/s10875-011-9571-1","article-title":"Altered phenotype and functionality of circulating immune cells characterize adult patients with nonalcoholic steatohepatitis","volume":"31","author":"Inzaugarat","year":"2011","journal-title":"J. Clin. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"104009","DOI":"10.1016\/j.micpath.2020.104009","article-title":"Contribution of endotoxin to Th17 bias in patients with non-alcoholic steatohepatitis","volume":"142","author":"Wang","year":"2020","journal-title":"Microb. Pathog."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10875-011-9635-2","article-title":"The role of innate cells is coupled to a Th1-polarized immune response in pediatric nonalcoholic steatohepatitis","volume":"32","author":"Inzaugarat","year":"2012","journal-title":"J. Clin. Immunol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Bertola, A., Bonnafous, S., Anty, R., Patouraux, S., Saint-Paul, M.C., Iannelli, A., Gugenheim, J., Barr, J., Mato, J.M., and Le Marchand-Brustel, Y. (2010). Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0013577"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2567.2009.03240.x","article-title":"Interleukin-17 and its target genes: Mechanisms of interleukin-17 function in disease","volume":"129","author":"Onishi","year":"2010","journal-title":"Immunology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2249.2011.04471.x","article-title":"Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease","volume":"166","author":"Tang","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"850246","DOI":"10.1155\/2015\/850246","article-title":"Nonalcoholic Steatohepatitis: Involvement of the Telomerase and Proinflammatory Mediators","volume":"2015","author":"Serhal","year":"2015","journal-title":"Biomed Res. Int."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Vonghia, L., Magrone, T., Verrijken, A., Michielsen, P., Van Gaal, L., Jirillo, E., and Francque, S. (2015). Peripheral and Hepatic Vein Cytokine Levels in Correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-Related Metabolic, Histological, and Haemodynamic Features. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0143380"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"110454","DOI":"10.1016\/j.celrep.2022.110454","article-title":"Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma","volume":"38","author":"Mirshahi","year":"2022","journal-title":"Cell Rep."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","article-title":"NASH limits anti-tumour surveillance in immunotherapy-treated HCC","volume":"592","author":"Pfister","year":"2021","journal-title":"Nature"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"603133","DOI":"10.3389\/fimmu.2021.603133","article-title":"Increased Frequency of Dysfunctional Siglec-7(-)CD57(+)PD-1(+) Natural Killer Cells in Patients With Non-alcoholic Fatty Liver Disease","volume":"12","author":"Sakamoto","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3389\/fimmu.2019.01255","article-title":"Retained NK Cell Phenotype and Functionality in Non-alcoholic Fatty Liver Disease","volume":"10","author":"Stiglund","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.3748\/wjg.v17.i13.1725","article-title":"Intrahepatic natural killer T cell populations are increased in human hepatic steatosis","volume":"17","author":"Adler","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/MEG.0b013e32831bc3d6","article-title":"Role of liver-infiltrating CD3+CD56+ natural killer T cells in the pathogenesis of nonalcoholic fatty liver disease","volume":"21","author":"Tajiri","year":"2009","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.4049\/jimmunol.1800614","article-title":"Differential Activation of Hepatic Invariant NKT Cell Subsets Plays a Key Role in Progression of Nonalcoholic Steatohepatitis","volume":"201","author":"Maricic","year":"2018","journal-title":"J. Immunol."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Romero-Cabrera, J.L., Ankeny, J., Fern\u00e1ndez-Montero, A., Kales, S.N., and Smith, D.L. (2022). A Systematic Review and Meta-Analysis of Advanced Biomarkers for Predicting Incident Cardiovascular Disease among Asymptomatic Middle-Aged Adults. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232113540"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijcard.2018.01.046","article-title":"Circulating Interleukin-6 is a biomarker for coronary atherosclerosis in nonalcoholic fatty liver disease: Results from the Multi-Ethnic Study of Atherosclerosis","volume":"259","author":"Simon","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Yoo, H.J., Hwang, S.Y., Choi, J.H., Lee, H.J., Chung, H.S., Seo, J.A., Kim, S.G., Kim, N.H., Baik, S.H., and Choi, D.S. (2017). Association of leukocyte cell-derived chemotaxin 2 (LECT2) with NAFLD, metabolic syndrome, and atherosclerosis. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0174717"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"880298","DOI":"10.3389\/fimmu.2022.880298","article-title":"Association of Inflammatory Cytokines with Non-Alcoholic Fatty Liver Disease","volume":"13","author":"Duan","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Lee, J., Yoon, K., Ryu, S., Chang, Y., and Kim, H.R. (2017). High-normal levels of hs-CRP predict the development of non-alcoholic fatty liver in healthy men. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0172666"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00535-009-0002-5","article-title":"High-sensitivity C-reactive protein as a serum predictor of nonalcoholic fatty liver disease based on the Akaike Information Criterion scoring system in the general Japanese population","volume":"44","author":"Kogiso","year":"2009","journal-title":"J. Gastroenterol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"390","DOI":"10.4103\/jfmpc.jfmpc_887_19","article-title":"Association of high-sensitivity C-reactive protein (hs-CRP) with non-alcoholic fatty liver disease (NAFLD) in Asian Indians: A cross-sectional study","volume":"9","author":"Kumar","year":"2020","journal-title":"J. Fam. Med. Prim. Care"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00535-007-2060-x","article-title":"High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH","volume":"42","author":"Yoneda","year":"2007","journal-title":"J. Gastroenterol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jhep.2010.12.017","article-title":"C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients","volume":"55","author":"Zimmermann","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/STROKEAHA.120.030433","article-title":"Severity of Nonalcoholic Fatty Liver Disease and Risk of Future Ischemic Stroke Events","volume":"52","author":"Xu","year":"2021","journal-title":"Stroke"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"9711712","DOI":"10.1155\/2022\/9711712","article-title":"High-Sensitivity C-Reactive Protein and Ischemic Stroke in Patients with Nonalcoholic Fatty Liver Disease: A Prospective Study","volume":"2022","author":"Jia","year":"2022","journal-title":"J. Healthc. Eng."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1012887","DOI":"10.3389\/fphys.2022.1012887","article-title":"Serum high-sensitive C-reactive protein is a simple indicator for all-cause among individuals with MAFLD","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Physiol."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Kim, J., Lee, D.Y., Park, S.E., Park, C.Y., Lee, W.Y., Oh, K.W., Park, S.W., and Rhee, E.J. (2017). Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammation. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0180118"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"L934","DOI":"10.1152\/ajplung.00034.2013","article-title":"NF-\u03baB pathway is involved in CRP-induced effects on pulmonary arterial endothelial cells in chronic thromboembolic pulmonary hypertension","volume":"305","author":"Wynants","year":"2013","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.7150\/ijbs.47143","article-title":"Kupffer Cells in Non-alcoholic Fatty Liver Disease: Friend or Foe?","volume":"16","author":"Chen","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41423-020-00580-w","article-title":"Immunopathobiology and therapeutic targets related to cytokines in liver diseases","volume":"18","author":"He","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1111\/jgh.15631","article-title":"Circulating tumor necrosis factor-\u03b1 levels in non-alcoholic fatty liver disease: A systematic review and a meta-analysis","volume":"36","author":"Potoupni","year":"2021","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/00365520701286680","article-title":"Importance of cytokines, oxidative stress and expression of BCL-2 in the pathogenesis of non-alcoholic steatohepatitis","volume":"42","author":"Torer","year":"2007","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Auguet, T., Bertran, L., Binetti, J., Aguilar, C., Mart\u00ednez, S., Sabench, F., Lopez-Dupla, J.M., Porras, J.A., Riesco, D., and Del Castillo, D. (2020). Relationship between IL-8 Circulating Levels and TLR2 Hepatic Expression in Women with Morbid Obesity and Nonalcoholic Steatohepatitis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21114189"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2036.2007.03586.x","article-title":"Adipokines and cytokines in non-alcoholic fatty liver disease","volume":"27","author":"Jarrar","year":"2008","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1053\/jhep.2001.29628","article-title":"Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients","volume":"34","author":"Crespo","year":"2001","journal-title":"Hepatology"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.3748\/wjg.v26.i33.4933","article-title":"Tumor necrosis factor alpha receptor 1 deficiency in hepatocytes does not protect from non-alcoholic steatohepatitis, but attenuates insulin resistance in mice","volume":"26","author":"Bluemel","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"e000349","DOI":"10.1136\/bmjgast-2019-000349","article-title":"Antitumour necrosis factor-\u03b1 agents and development of new-onset cirrhosis or non-alcoholic fatty liver disease: A retrospective cohort","volume":"7","author":"Tang","year":"2020","journal-title":"BMJ Open Gastroenterol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/hep.28389","article-title":"NKp46(+) natural killer cells attenuate metabolism-induced hepatic fibrosis by regulating macrophage activation in mice","volume":"63","author":"Krueger","year":"2016","journal-title":"Hepatology"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"eaal3694","DOI":"10.1126\/scitranslmed.aal3694","article-title":"Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-\u03b2","volume":"9","author":"Hart","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3389\/fimmu.2015.00602","article-title":"Macrophages During the Fibrotic Process: M2 as Friend and Foe","volume":"6","author":"Braga","year":"2015","journal-title":"Front. Immunol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1172\/JCI121842","article-title":"STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis","volume":"129","author":"Yu","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"G891","DOI":"10.1152\/ajpgi.00193.2013","article-title":"IFN-\u03b3 deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet","volume":"305","author":"Luo","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_126","first-page":"819","article-title":"Effect of interferon-gamma on hepatic fibrosis in chronic hepatitis B virus infection: A randomized controlled study","volume":"3","author":"Weng","year":"2005","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jhep.2017.03.003","article-title":"CD44 is a key player in non-alcoholic steatohepatitis","volume":"67","author":"Patouraux","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"G1281","DOI":"10.1152\/ajpgi.00074.2008","article-title":"Gene expression in human NAFLD","volume":"294","author":"Greco","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.2337\/db07-0156","article-title":"Genes involved in fatty acid partitioning and binding, lipolysis, monocyte\/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects","volume":"56","author":"Westerbacka","year":"2007","journal-title":"Diabetes"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"e30184","DOI":"10.1097\/MD.0000000000030184","article-title":"Integrated bioinformatics analysis reveals potential mechanisms associated with intestinal flora intervention in nonalcoholic fatty liver disease","volume":"101","author":"Liu","year":"2022","journal-title":"Medicine"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jhep.2006.02.011","article-title":"Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2","volume":"44","author":"Haukeland","year":"2006","journal-title":"J. Hepatol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"e954","DOI":"10.1097\/MEG.0000000000002324","article-title":"The promising role of CCL2 as a noninvasive marker for nonalcoholic steatohepatitis diagnosis in Egyptian populations","volume":"33","author":"Ali","year":"2021","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Puengel, T., Lefere, S., Hundertmark, J., Kohlhepp, M., Penners, C., Van de Velde, F., Lapauw, B., Hoorens, A., Devisscher, L., and Geerts, A. (2022). Combined Therapy with a CCR2\/CCR5 Antagonist and FGF21 Analogue Synergizes in Ameliorating Steatohepatitis and Fibrosis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23126696"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","article-title":"Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis","volume":"158","author":"Schwabe","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/hep.26698","article-title":"Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatology"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1046\/j.1365-2036.2001.01083.x","article-title":"Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: A pilot study","volume":"15","author":"Hasegawa","year":"2001","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.molmed.2018.03.005","article-title":"IL-1 Family Cytokine Pathways Underlying NAFLD: Towards New Treatment Strategies","volume":"24","author":"Mirea","year":"2018","journal-title":"Trends Mol. Med."},{"key":"ref_138","first-page":"101","article-title":"Interleukin-18-deficient mice develop dyslipidemia resulting in nonalcoholic fatty liver disease and steatohepatitis","volume":"173","author":"Yamanishi","year":"2016","journal-title":"Transl. Res. J. Lab. Clin. Med."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"971745","DOI":"10.3389\/fendo.2022.971745","article-title":"Interleukin-18 in metabolism: From mice physiology to human diseases","volume":"13","author":"Somm","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Hohenester, S., Kanitz, V., Schiergens, T., Einer, C., Nagel, J., Wimmer, R., Reiter, F.P., Gerbes, A.L., De Toni, E.N., and Bauer, C. (2020). IL-18 but Not IL-1 Signaling Is Pivotal for the Initiation of Liver Injury in Murine Non-Alcoholic Fatty Liver Disease. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228602"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Cyr, B., Keane, R.W., and de Rivero Vaccari, J.P. (2020). ASC, IL-18 and Galectin-3 as Biomarkers of Non-Alcoholic Steatohepatitis: A Proof of Concept Study. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228580"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1023\/A:1020600230977","article-title":"Plasma levels of interleukin-18 and interleukin-18 binding protein are elevated in patients with chronic liver disease","volume":"22","author":"Ludwiczek","year":"2002","journal-title":"J. Clin. Immunol."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Mehta, R., Neupane, A., Wang, L., Goodman, Z., Baranova, A., and Younossi, Z.M. (2014). Expression of NALPs in adipose and the fibrotic progression of non-alcoholic fatty liver disease in obese subjects. BMC Gastroenterol., 14.","DOI":"10.1186\/s12876-014-0208-8"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"9914","DOI":"10.1073\/pnas.1304046110","article-title":"Eosinophils secrete IL-4 to facilitate liver regeneration","volume":"110","author":"Goh","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_145","first-page":"205","article-title":"IL-6-deficient mice are susceptible to ethanol-induced hepatic steatosis: IL-6 protects against ethanol-induced oxidative stress and mitochondrial permeability transition in the liver","volume":"1","author":"Hong","year":"2004","journal-title":"Cell. Mol. Immunol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"905936","DOI":"10.3389\/fphar.2022.905936","article-title":"Interleukin-6 Receptor Blockade can Increase the Risk of Nonalcoholic Fatty Liver Disease: Indications From Mendelian Randomization","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharm."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/labinvest.2010.75","article-title":"Blockade of interleukin-6 signaling enhances hepatic steatosis but improves liver injury in methionine choline-deficient diet-fed mice","volume":"90","author":"Yamaguchi","year":"2010","journal-title":"Lab. Invest."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Mas, E., Danjoux, M., Garcia, V., Carpentier, S., S\u00e9gui, B., and Levade, T. (2009). IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0007929"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1053\/jhep.2003.50316","article-title":"Cytokines and NASH: A pilot study of the effects of lifestyle modification and vitamin E","volume":"38","author":"Kugelmas","year":"2003","journal-title":"Hepatology"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/j.1572-0241.2007.01774.x","article-title":"Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis","volume":"103","author":"Wieckowska","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1089\/wound.2019.1032","article-title":"The Role of the Anti-Inflammatory Cytokine Interleukin-10 in Tissue Fibrosis","volume":"9","author":"Steen","year":"2020","journal-title":"Adv. Wound Care"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"708959","DOI":"10.3389\/fimmu.2021.708959","article-title":"Crosstalk Between Plasma Cytokines, Inflammation, and Liver Damage as a New Strategy to Monitoring NAFLD Progression","volume":"12","author":"Mattos","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ccell.2016.05.020","article-title":"Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma","volume":"30","author":"Gomes","year":"2016","journal-title":"Cancer Cell"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/2313\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:14:46Z","timestamp":1760120086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/2313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,24]]},"references-count":153,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["ijms24032313"],"URL":"https:\/\/doi.org\/10.3390\/ijms24032313","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,24]]}}}